meds for buy
WORKING GROUPS SEMINARS
REGIONAL CONGRESSES OF THE HELLENIC CARDIOLOGICAL SOCIETY
WORKING GROUPS-OLD STRUCTURE
WORKING GROUPS-NEW STRUCTURE
HELLENIC JOURNAL OF CARDIOLOGY
ACTIONS OF THE HELLENIC CARDIOLOGICAL SOCIETY
NEWS FROM ESC
Valvular Heart Disease
Coronary Artery Disease
Myocardial Infarction. How much are we at risk?
COMPENDIUM of Abridged ESC Guidelines 2010
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Prevention of Cardiovascular Disease
FDA finally gives a thumbs-up for cangrelor
After close to a decade of late-stage studies and stinging setbacks, The Medicines Co. may finally be on the verge of seeing its...
New administration option for ticagrelor now approved
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by...
FDA: Use of TAVR system expanded to include aortic valve-in-valve replacement
The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press...
FDA approves expansion of clinical trial for left ventricular assist system
Thoratec Corporation announced that it has received approval from the FDA to expand enrollment of the HeartMate III U.S. Clinical trial of a...
Medtronic’s CoreValve Bests Surgery at Two-Year Mark
Medtronic said recently that data from a U.S. pivotal trial showed patients who underwent transcatheter aortic valve replacement using...
FDA approves blood pump system for patients undergoing high-risk PCI
The FDA announced that it has approved a miniature blood pump system to help patients undergoing certain high-risk PCI procedures maintain...
Boston Sci's stroke-fighting Watchman overcomes years of regulatory roadblocks, wins FDA approval
Boston Scientific finally won FDA approval for its stroke-fighting Watchman device after setbacks and rejections in 2010 and 2014. The...
AMERICAN COLLEGE OF CARDIOLOGY (ACC) 2015
LEGACY: Weight loss improves AF burden New data from the LEGACY study suggest that long-term sustained weight loss may be an important strategy...
Boehringer Ingelheim files BLA for antidote to dabigatran
Boehringer Ingelheim announced that it has submitted a biologics license application to the FDA requesting an accelerated approval pathway for...
Insertable cardiac monitors effective, provide value for poststroke AF
NASHVILLE, Tenn. — Two studies of insertable cardiac monitors presented at the International Stroke Conference demonstrated that the...
FDA grants priority review for investigational HF treatment
Novartis announced that the FDA has granted a priority review designation to its investigational LCZ696 for the treatment of patients with HF and...
ANNEXA-R: Antidote to novel oral anticoagulant met primary endpoint
Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the...
FDA accepts alirocumab for priority review
Sanofi and Regeneron announced that the FDA has accepted the companies’ Biologics License Application for the proprotein convertase...
FDA approves edoxaban to reduce stroke risk, treat AF, DVT and PE
The FDA and Daiichi Sankyo announced that the agency has approved edoxaban to reduce the risk for stroke and systemic embolism in patients with...
FDA did not approve nebivolol/valsartan combination to treat hypertension
Actavis plc announced that it received a complete response letter from the FDA indicating that its fixed-dose combination of nebivolol and...
FDA approves two left ventricular quadripolar leads for CRT-Ds
Medtronic recently announced that it has received FDA approval of two left ventricular quadripolar leads for use with cardiac resynchronization...
FDA approves Saxenda injection therapy for weight management
The FDA granted approval to liraglutide 3-mg injection as the first once-daily human glucagon-like peptide-1 analogue to help manage...
AHA 2014 TOP NEWS
IMPROVE-IT: 'Modest' benefit with ezetimibe after ACS DAPT: A risk-benefit balance with long-term dual antiplatelet therapy after ...
The European Medicines Agency has completed a reassessment of ivabradine
The European Medicines Agency has completed a reassessment of ivabradine The Committee for Medicinal Products for Human Use of the European...
FDA advisory panel split on revote for LAA closure device
Τhe FDA’s Circulatory System Devices Panel split its vote today after reconsidering whether a left atrial appendage closure device should...
GIANT CARDIAC HYDATID CYST WITH RARE ADHESIONS
We present a 29-year-old woman admitted...
QUADRICUSPID PULMONARY VALVE IN AN ADULT PATIENT
We describe a case of quadricuspid pulmonary...
Apixaban does not increase bleeding in patients with renal insufficiencies
Compared with conventional anticoagulants, use of apixaban resulted in a lower bleeding risk in patients with mild or moderate-to-severe renal impairment, according to results of a...
Patient genotyping identifies increased bleeding risk with warfarin treatment
Patients with a genetic sensitivity to warfarin and increased rates of bleeding in the first several months of treatment stand to benefit from use of an alternate anticoagulant drug, according to...
Amiodarone associated with acute pancreatitis in patients with AF
Acute pancreatitis could be an adverse effect of amiodarone use in patients with atrial fibrillation, according to results of a nested case-control study. An association...
Ranolazine Reduces the Late Recurrences of Atrial Fibrillation.
The 500+750 mg RAN doses reduced the recurrence of AF compared with placebo + the ineffective 375 mg dose. The data suggest that ranolazine may be less effective early after CV when...
Elevated circulating troponin linked to AF risk in older adults
In ambulatory older adults, circulating troponin T levels appear to be significantly associated with incident atrial fibrillation, according to recent findings. Heart...
Commonly used clinical risk calculators overestimate CV events
Four commonly used risk scores, including the newer American College of Cardiology/American Heart Association atherosclerotic CVD risk score, may overestimate CV events by up to 67% in women...
High-dose statin reduced risk for contrast-induced nephropathy
High-dose rosuvastatin at admission reduced the occurrence of contrast-induced acute kidney injury in patients with ACS and elevated high-sensitivity C-reactive protein levels who were...
Moderate alcohol consumption associated with lower risk for incident HF
Consumption of seven or fewer alcoholic beverages per week was associated with lower risk for incident HF compared with no alcohol consumption during early middle-age among participants in...
Patients with AF, CHA2DS2-VASc score of 1 may be at low risk for ischemic stroke
Patients with atrial fibrillation and a CHA2DS2-VASc score of 1 may be at lower risk for ischemic stroke than previously thought, according to the results of a retrospective study. These...
Daily avocado consumption improved LDL cholesterol
Adults who adhered to a moderate-fat diet and consumed an avocado each day exhibited greater improvements to LDL cholesterol compared with adults on a similar diet that did not include avocado,...
Isolated systolic hypertension conferred higher mortality risk in young adults
Isolated systolic hypertension during young and middle age was associated with increased long-term risk for death related to CVD and CHD compared with optimal BP. Researchers analyzed...
Niacin lowered PCSK9 levels
Niacin is associated with a reduction in PCSK9 levels, according to new findings. This association could help explain how niacin reduces LDL, and could offset increases in PCSK9 levels...
Register to receive our Newsletter:
36th International Congress of Cardiology- Abstract Submission
March 30 2015
We would like to inform you that the 36th International Cardiology Congress is due to take place on October 29-31 2015, in Thessaloniki, Greece...
ESC CONGRESS 2015
March 23 2015
29 Aug 2015 - 02 Sep 2015 , London - United Kingdom Please browse through the...
World Heart Federation Members Webinar: CVD and the Development Agenda: Advocacy Toolkit- Wednesday 18 March, 16:00 Central European Time
March 17 2015
New Webinar frome the Word Heart Federation. Click here for more details.
ESC Congress News 2014
September 11 2014
Please find below the most important ESC Congress News 2014 SATURDAY 30 AUGUST SUNDAY 31 AUGUST MONDAY 1 SEPTEMBER TUESDAY 2 SEPTEMBER WEDNESDAY...
INAUGUAL SESSION ESC Congress 2014
August 19 2014
INAUGUAL SESSION ESC Congress 2014 Saturday 30 August Barcelona - Central Village 16:30-18:00 We invite all delegates to join this...
Catalogue with the most influential Greek scientists
August 7 2014
The list with the most influential Greek scientists is part of a study conducted by Prof. John Ioannidis (University of Ioannina &...
RAFFTING PUBLICATION IN THE INTERNATIONAL JOURNAL OF CARDIOLOGY
August 1 2014
Results from the official Registry of the Hellenic Society of Cardiology RAFTING (Registry of Atrial Fibrillation To Investigate New Guidelines)...
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 26 2014
We would like to inform you that the deadline for abstract submission is extended until 30/5/2014.
HEART FAILURE 2014- Athens 17-20 May, OPENING CEREMONY
May 13 2014
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 7 2014
We would like to inform you that the deadline for abstract submission is extended until 18/5/2014.
HEART FAILURE 2014- Athens 17-20 May, Free Registration for Greek Residents
April 24 2014
Cardiology Update 2015 21st International Postgraduate Course on Cardiovascular Disease
April 8 2014
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
March 25 2014
Volume: 15 / Number: 4 / Publication Date: March 2014 / Owner: European Society of Cardiology
U.E.M.S. Cardiology Section
February 13 2014
Dear delegates to UEMS Cardiology Section, this is to notify you that the European Society of Cardiology (ESC) and UEMS Cardiology Section (CS),...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
January 28 2014
Volume: 15 / Number: 2 / Publication Date: February 2014 / Publisher: European Society of Cardiology
REGISTRATION AT HEART FAILURE 2014 IN ATHENS
January 21 2014
Τhe HFA Board has designed special prices for the Greek participants: -Free for Local Medical Students -200€ for local...
INNOVATION IN EDUCATION AT WORK
January 20 2014
For more information please click here.
SURGERY IN SEVERE MITRAL REGURGITATION: FOCUS ON PATIENTS WITH NO SYMPTOMS OR COMPLICATIONS
An article from the e-journal of the ESC Council for Cardiology Practice Mitral valve repair is often recommended in severe mitral regurgitation...
HEART FAILURE 2014 ABSTRACT SUBMISSION
Abstract submission deadline: 21 January 2014. For more information please click here.
PRESS RELEASE ABOUT SYMPLICITY HTN-3
In light of Medtronic’s announcement of Thursday, 9th January 2014, about SYMPLICITY HTN-3, the Resistant Hypertension Course Scientific...
ACC.15 Wrap Up Day 3
ACC.15 Wrap Up Day 2
ACC.15 Wrap Up Day 1
Best of ESC Congress 2014 - 04 sept 2014
Επίδειξη Σεμιναρίου ALS (Advanced Life Support- Εξειδικευμένη Υποστήριξη Ζωής) σε σεμινάριο στην Ελληνική Καρδιολογική Εταιρεία, σε συνεργασία με το ERC (European Resuscitation Council)
Πρόεδρος ΕΚΕ Ι. Καλλικάζαρος
Υπεύθυνος ALS Γ. Λάτσιος
Map - Location
6 Potamianou 11528 Athens
Phone: +30 210 722 1633, 210 725 8003-8
Fax: +30 210 722 6139
Follow us on Facebook and Twitter
Powered: By Inspirit Graphics Studio